Fig. 2From: Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot studyClinical improvement from baseline, the onset day of inhalation treatment, in individual patients in the MEXCOVID study. A Changes in oxygen-support status from baseline in individual patients. B Cumulative incidence of clinical improvement from the onset of neublization. C–F Changes of chest CT scan before and after haMSC-Exos inhalation in COVID-19 patientsBack to article page